Search results
Formerly President at Polyplus group (now part of Sartorius) for 14 years (2009-2023), Founder and President at GeneSystems (2000-2008), meanwhile advisor to financial investors, Gabriel has experienced leadership, strategic decision making along with day-to-day operational management.
Gabriel FESTOC, CEO | Cited by 241 | of Polyplus-Transfection, Illkirch-Graffenstaden | Read 4 publications | Contact Gabriel FESTOC.
Feb 22, 2023 · In addition, the board of directors welcomes Dr. Gabriel Festoc, former President of Polyplus, as an independent director. Gabriel brings valuable experience in successfully building and growing companies in the PCR as well as Biopharma industry.
Oct 3, 2016 · “ArchiMed’s deep knowledge of our industry, including the specific transfection space, and the team’s impressive global network in Healthcare and life sciences makes them the ideal growth catalyst for us,” says Gabriel Festoc, Polyplus’ CEO.
- Maxime Dumont
- ldidier
Gabriel Festoc is Former Chairman at Polyplus-Transfection SA. See Gabriel Festoc's compensation, career history, education, & memberships.
- Former Chairman
- Polyplus-Transfection SA
“Given the operational experience and science backgrounds of most of the ARCHIMED team, they understood our potential and what it would take to realize it when many others didn’t,” says Gabriel Festoc, President of Polyplus.
“Backed by their significant experience in healthcare and extensive network of resources, we are confident that Warburg Pincus, alongside ARCHIMED, will further accelerate our market leadership by delivering increased value for the customers we serve,” said Gabriel Festoc, Chairman of the Executive Board at PolyGenX, the organization that ...
